Vitamin D Partially Modifies the Impaired Wnt/β-Catenin Pathway in Endometriosis

Home » Lifestyle » Vitamin D Partially Modifies the Impaired Wnt/β-Catenin Pathway in Endometriosis

By



Attention: You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Vitamin D partially modifies the impaired wntβ-catenin pathway in endometriosis

The modulating effects of vitamin D on the activity of β-catenin in the endometrium of women with endometriosis: a randomized exploratory trial

A small prospective randomized trial involving women with stage III and IV endometriosis was carried out to investigate the effects of vitamin D on the protein β-catenin, and the Wnt/β-catenin pathway, which is over-activated in the endometrium of women with endometriosis.

A total of 34 women meeting the inclusion criteria had two endometrial tissue and blood samples collected, during the mid-secretory phase and on cycle day 21, pre and post trial. In the intervention group, 17 women took 50,000 IU of vitamin D orally for 12 to 14 weeks. Baseline characteristics of both groups (intervention and control) showed no significant difference in mean BMI (27.1 ± 1), age or serum concentration of vitamin D.

Initial analysis post treatment, showed that serum levels of vitamin D was significantly elevated in the intervention group (35.19 ±3.35) compared to the control group (13.26 ±1.49). Interestingly mRNA expression of β-catenin was not significantly altered post treatment in the intervention group and differ between the 2 groups.

Further analysis identified that levels of active β-catenin was significantly lowered in the intervention groups tissue samples post treatment. This finding remained true when analysed as a ratio of active β-catenin/total β-catenin, between both groups, before and after treatment.


SUMMARY: CAN VITAMIN D TREAT ENDOMETRIOSIS

In this study, vitamin D treatment in women with endometriosis, showed that supplementation decreased the overactivated Wnt/β-catenin pathway, in the tissue samples of women with endometriosis, confirming a complementary role of vitamin D in the treatment of endometriosis.


Limitations

  1. Non-blinded placebo control trial


Similar studies

Pazhohan A, et al. (2018). Expression and shedding of CD44 in the endometrium of women with endometriosis and modulating effects of vitamin D: a randomized exploratory trial. https://doi.org/10.1016/j.jsbmb.2017.12.001

Pazhohan A, et al. (2018). The Wnt/β-catenin signaling in endometriosis, the expression of total and active forms of β-catenin, total and inactive forms of glycogen synthase kinase-3β, WNT7a and DICKKOPF-1. https://doi.org/10.1016/j.ejogrb.2017.10.025

Harris H R, et al. (2013). Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. https://doi.org/10.1093/aje/kws247

Agic A, et al. (2007). Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers. https://doi.org/10.1177/1933719107304565


fertilPEDIA

Unexplained infertility is defined as the failure to conceive after 12 months of regular unprotected sexual intercourse and no identifiable cause following…. Read more

Endometriosis Overview

Endometriosis is a common yet complex gynecological inflammatory disease characterized by the growth of endometrial-like tissue outside the…. Read more

Questions or comments?